Outcomes and Complications of In-Office Laser Demarcation of Peripheral Rhegmatogenous Retinal Detachments

Copyright 2020, SLACK Incorporated.

Bibliographische Detailangaben
Veröffentlicht in:Ophthalmic surgery, lasers & imaging retina. - 2013. - 51(2020), 8 vom: 01. Aug., Seite 428-434
1. Verfasser: Xu, David (VerfasserIn)
Weitere Verfasser: Levin, Hannah J, Garrigan, Hannah, Wibbelsman, Turner D, Obeid, Anthony, Pandit, Ravi R, Jenkins, Thomas L, Mehta, Sonia, Ho, Allen C, Hsu, Jason, Regillo, Carl D
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2020
Zugriff auf das übergeordnete Werk:Ophthalmic surgery, lasers & imaging retina
Schlagworte:Journal Article
LEADER 01000naa a22002652 4500
001 NLM313920826
003 DE-627
005 20231225151621.0
007 cr uuu---uuuuu
008 231225s2020 xx |||||o 00| ||eng c
024 7 |a 10.3928/23258160-20200804-02  |2 doi 
028 5 2 |a pubmed24n1046.xml 
035 |a (DE-627)NLM313920826 
035 |a (NLM)32818274 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Xu, David  |e verfasserin  |4 aut 
245 1 0 |a Outcomes and Complications of In-Office Laser Demarcation of Peripheral Rhegmatogenous Retinal Detachments 
264 1 |c 2020 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 21.07.2021 
500 |a Date Revised 21.07.2021 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Copyright 2020, SLACK Incorporated. 
520 |a BACKGROUND AND OBJECTIVE: To evaluate the outcomes of in-office laser demarcation (LD) for peripheral rhegmatogenous retinal detachments (RRDs) 
520 |a PATIENTS AND METHODS: This was a retrospective analysis of peripheral RRDs treated with LD. Patient demographics, visual acuity (VA), and RRD characteristics were recorded. Complications requiring additional procedures were recorded. Multiple logistic regression was used to characterize the association of RRD anatomy to treatment complications 
520 |a RESULTS: A total of 112 eyes of 107 patients were analyzed with mean follow-up of 20 ± 12 months. VA at baseline and last follow-up was equivalent (0.16 logMAR, Snellen equivalent 20/29). Ninety-five (84.8%) eyes were successfully treated without an additional procedure. In multivariate analysis, the presence of VH (odds ratio [OR] = 4.0; 95% confidence interval [CI], 1.1-17; P = .04) and RRDs in the inferior 6 clock hours (OR = 6.2; 95% CI, 1.5-29; P = .01) were associated with complications 
520 |a CONCLUSIONS: LD is successful in treating peripheral RRDs. RRD characteristics less conducive to laser include presence of VH and inferior RRD. [Ophthalmic Surg Lasers Imaging Retina. 2020;51:428-434.] 
650 4 |a Journal Article 
700 1 |a Levin, Hannah J  |e verfasserin  |4 aut 
700 1 |a Garrigan, Hannah  |e verfasserin  |4 aut 
700 1 |a Wibbelsman, Turner D  |e verfasserin  |4 aut 
700 1 |a Obeid, Anthony  |e verfasserin  |4 aut 
700 1 |a Pandit, Ravi R  |e verfasserin  |4 aut 
700 1 |a Jenkins, Thomas L  |e verfasserin  |4 aut 
700 1 |a Mehta, Sonia  |e verfasserin  |4 aut 
700 1 |a Ho, Allen C  |e verfasserin  |4 aut 
700 1 |a Hsu, Jason  |e verfasserin  |4 aut 
700 1 |a Regillo, Carl D  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Ophthalmic surgery, lasers & imaging retina  |d 2013  |g 51(2020), 8 vom: 01. Aug., Seite 428-434  |w (DE-627)NLM224956647  |x 2325-8179  |7 nnns 
773 1 8 |g volume:51  |g year:2020  |g number:8  |g day:01  |g month:08  |g pages:428-434 
856 4 0 |u http://dx.doi.org/10.3928/23258160-20200804-02  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_40 
912 |a GBV_ILN_63 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_90 
912 |a GBV_ILN_91 
912 |a GBV_ILN_130 
912 |a GBV_ILN_135 
912 |a GBV_ILN_136 
912 |a GBV_ILN_151 
912 |a GBV_ILN_181 
912 |a GBV_ILN_203 
912 |a GBV_ILN_217 
912 |a GBV_ILN_235 
912 |a GBV_ILN_289 
912 |a GBV_ILN_294 
912 |a GBV_ILN_297 
912 |a GBV_ILN_350 
912 |a GBV_ILN_352 
912 |a GBV_ILN_674 
912 |a GBV_ILN_676 
912 |a GBV_ILN_688 
912 |a GBV_ILN_698 
912 |a GBV_ILN_721 
912 |a GBV_ILN_737 
912 |a GBV_ILN_791 
912 |a GBV_ILN_812 
951 |a AR 
952 |d 51  |j 2020  |e 8  |b 01  |c 08  |h 428-434